Team:Evry Paris-Saclay/Improve


TO CONTACT US
Genopole Campus 1, Batiment 6, 91030 Evry Cedex, France
+33 7 69 96 68 31
igemevry@gmail.com

© Copyright 2018
Design & Developpement by
IGEM EVRY GENOPOLE

THE PEPTIDE

In our system, the hexapeptide SAIRGA is the signalling molecule used for cell-to-cell communication [1]. To perform its quorum sensing function in the natural phi3T phage infection, SAIRGA needs to be secreted out of the cell. It is produced as an immature pre-pro-peptide, AimP (BBa_K2279001), that upon secretion is cleaved extracellularly to remove the secretion signal and release the mature hexapeptide. The mature peptide then re-enters cells and binds to its receptor protein AimR (BBa_K2279000). Binding of SAIRGA to AimR blocks the activator function of AimR that, in turn, facilitates a switch from lytic-to-lysogenic viral cycle. By acting as a negative regulator of AimR, the SAIRGA signal makes the lysis-to-lysogeny switch of phi3T phage dependent on the “quorum” of phi3T phages in the bacterial population.



DESIGN

In phi3T phage, SAIRGA is produced as AimP (BBa_K2279001) with specific secretion and protease-cleavage tags [1] that allow secretion and extracellular processing by Bacillus. Since we had no further information about this protease, we could not investigate the ability of Escherichia coli to produce a similar enzyme. Consequently, to produce SAIRGA in E. coli, we decided to replace this tag by an E. coli secretion signal. We have investigated three different secretion signals: OmpA (BBa_K208003), PelB (BBa_J32015) and Tat of csp2 gene of Corynebacterium glutamicum (Uniprot Q04985).

To express them in E. coli, we codon optimized all sequences for E. coli DH5α, designed specific RBSs with the Salis Lab RBS Calculator [2, 3] and placed these peptides under the control of the constitutive strong promoter BBa_J23100. Thus, we generated four SAIRGA expression plasmids (BBa_K2675041, BBa_K2675042, BBa_K2675043 and BBa_K2675044).

Part Name Translated CDS Sequence Part Number Expression Cassette Part Number
AimP MKKVFFGLVILTALAISFVAGQQSVSTASASDEVTVASAIRGA BBa_K2675001 BBa_K2675041
OmpA-SAIRGA MKKTAIAIAVALAGFATVAQASAIRGA BBa_K2675002 BBa_K2675042
PelB-SAIRGA MKYLLPTAAAGLLLLAAQPAMASAIRGA BBa_K2675003 BBa_K2675043
Tat-SAIRGA MFNNRIRTAALAGAIAISTAASGVAIPAFASAIRGA BBa_K2675004 BBa_K2675044

EXPERIMENTAL SETUP

E. coli DH5α harboring the SAIRGA expression plasmids were grown at 37°C in mineral salts medium [4] containing 2 mg/mL glucose and 35 μg/mL chloramphenicol (Figure 8). During the culturing, samples were prelevated, centrifuged and the supernatant was first sterilised by filtering through a 0.22 µm membrane, then loaded on a Pall Nanosep centrifugal device with Omega membrane (MWCO 3 kDa). The low molecular weight fraction of the culturing media thus recovered was analysed by LC-MS: ultra high pressure liquid column chromatography (UPLC) on a ACQUITY HSS T3 1.8 µM, 2.1 x 100 mm column (Waters) coupled with a Xevo G2-S Qtof mass spectrometer (Waters). The chromatography was performed using a gradient of using a (A) 1% formic acid in whater / (B) 1% formic acid in acetonitrile with the following program: from 0 to 5 min solvent B was increased from 2% to 70%, then it was maintained for 1 min at 70%; aftrewards it was decreased in 30 sec to 2% and it was maintained at 2% for 3.5 min for column re-equilibration. The flow rate was 0.2 mL/min and the column temperature was set to 45°C. The ions were detected in resolution negative mode.

The pure synthetic SAIRGA peptide was readily detected by LC-MS. As shown in Figures 1 and 2, a peak of 572 Da, which correspond to SAIRGA’s monoisotopic mass [M-H]- was observed at a retention time of 3.9 min (Figure 3). The area under the curve is proportional to the concentration of SAIRGA (Figure 4).

Figure 1: Mass spectrometry analysis of SAIRGA’s fraction obtained with various amounts of pure synthetic SAIRGA peptide.
Figure 2: Mass spectrometry analysis of SAIRGA’s fraction obtained with 5 µM of pure synthetic SAIRGA peptide (zoom on SAIRGA’s peak).
Figure 3: UPLC chromatograms obtained with various amount of pure synthetic SAIRGA peptide.
Figure 4: Standard curve of the area under the curve obtained by UPLC as a function of the concentration of SAIRGA.

RESULTS

LC-MS analysis of samples isolated from the fermentation broth of the E. coli strains harbouring a SAIRGA expression plasmid was performed.

As shown in Figures 5 and 6, the expression vector of OmpA-SAIRGA (BBa_K2675042) is able to produce a compound with a monoisotopic mass a peak of 572 Da, which correspond to SAIRGA’s monoisotopic mass [M-H]- at a retention time of 3.9 min. The size or the area under the peak is increasing with time (figure 7). This suggests that OmpA is an efficient E. coli secretion tag which allows the release of the mature peptide SAIRGA in the culturing media.

Figure 5: Mass spectrometry of culturing media taken after 2, 4, 6 and 8 hours of incubation of E. coli cells harboring the OmpA-SAIRGA expression cassette in pSB1C3 (BBa_K2675042). The negative control has been performed with an empty pSB1C3 (bottom red chromatogram). The positive control (pure synthetic SAIRGA at 5 µM) is represented as the top red chromatogram.
Figure 6: UPLC chromatograms of culturing media taken after 2, 4, 6 and 8 hours of incubation of E. coli cells harboring the OmpA-SAIRGA expression cassette in pSB1C3 (BBa_K2675042). The negative control has been performed with an empty pSB1C3 (bottom green chromatogram). The positive control (pure synthetic SAIRGA at 5 µM) is represented as the top red chromatogram.
Figure 7: SAIRGA production at 37°C by E. coli cells harboring the various SAIRGA expression plasmids (BBa_K2675041, BBa_K2675042, BBa_K2675043 and BBa_K2675044). The negative control has been performed with an empty pSB1C3.
Figure 8: Growth curves at 37°C of E. coli cells harboring the various SAIRGA expression plasmids (BBa_K2675041, BBa_K2675042, BBa_K2675043 and BBa_K2675044). The negative control has been performed with an empty pSB1C3.

The other parts (BBa_K2675041, BBa_K2675043 and BBa_K2675044) did not show any peak at 572 Da, which suggests that the native Bacillus secretion tag, as well as PelB and Tat signals are not able to secrete the mature peptide. We suspect that, in each case, the pro-peptide is produced and released but its secretion tag is not cleaved by the cell.

Moreover, after 24h of incubation, we were unable to detect the SAIRGA peptide in the culturing media (Figures 9 and 10). This is probably due to the exhaustion of the medium: and the instability of the secreted peptide in the medium.

Figure 9: UPLC chromatogram obtained with media taken after 24h of incubation of E. coli cells harboring the OmpA-SAIRGA expression cassette in pSB1C3 (BBa_K2675042).
Figure 10: Mass spectrometry analysis of the media taken after 24h of incubation of E. coli cells harboring the OmpA-SAIRGA expression cassette in pSB1C3 (BBa_K2675042).

CONCLUSION

We have successfully built a part, OmpA-SAIRGA (BBa_K2675002), which is able to produce and release the mature hexapeptide SAIRGA in the culturing media of E. coli cells harboring this part equipped with an RBS and under the control of a constitutive promoter (BBa_K2675042).

Thus, we have made an improvement of the BBa_K2279001, the SAIRGA peptide with the original secretion signal, that is not functional in E. coli under un equivalent transcriptional and translational control (BBa_K2675041).

REFERENCES

[1] Erez Z, Steinberger-Levy I, Shamir M, Doron S, Stokar-Avihail A, Peleg Y, Melamed S, Leavitt A, Savidor A, Albeck S, Amitai G, Sorek R. Communication between viruses guides lysis-lysogeny decisions. Nature (2017) 541, 488-493.

[2] Espah Borujeni A, Channarasappa AS, Salis HM. Translation rate is controlled by coupled trade-offs between site accessibility, selective RNA unfolding and sliding at upstream standby sites. Nucleic Acids Res (2014) 42, 2646-2659.

[3] Salis HM, Mirsky EA, Voigt CA. Automated design of synthetic ribosome binding sites to control protein expression. Nat Biotechnol (2009) 27, 946-50.

[4] Hall BG. Activation of the bgl operon by adaptive mutation. Mol Biol Evol (1998) 15, 1-5.